Magnetic Resonance Imaging Can Be Used to Assess Sarcopenia in Children with Newly Diagnosed Crohn’s Disease
Nutrients · 2023
DOI: 10.3390/nu15173838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Paola Blagec und 6 weiteren Autor:innen. Beteiligte Einrichtung: Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Sarcopenia, Crohn Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
This study aimed to determine the proportion of patients with sarcopenia diagnosed by MRI and compare these results to bioelectrical impedance analysis (BIA).
Methods
Children with newly diagnosed Crohn’s disease (CD) who had MRI enterography (MRE) and BIA and had at least 12 months of follow-up were included. Total psoas muscle area (TPMA) and total paravertebral muscle (TPVM) were measured and compared to subjects’ lean mass and the lean mass body index (LMBI) was assessed by BIA.
Results
30 newly diagnosed children with CD were included (mean age 14.2 years, 53% male). Sarcopenia was found in 13 (43%) children; mean TPMA was 15.2 (1.1 SD) cm2 and TPVM 30.95 (1.7 SD) cm2. A highly positive correlation was shown for lean mass assessed by BIA and TPMA (0.706, p < 0.001) and TPVM (0.75, p < 0.001). Sarcopenia was more prevalent in boys (77% vs. 24%, p = 0.004), patients with the perianal disease (69% vs. 29%, p = 0.03), and children with sarcopenia were likely to receive anti-TNF (77% vs. 41%, p = 0.05). During the follow-up period, 16 (53%) children experienced a relapse. TPMA (HR 0.99, p = 0.018) and TPVM (HR 0.99, p = 0.031) values were statistically significant risk factors for relapse.
Conclusion
A high proportion of patients with CD have sarcopenia at the time of the diagnosis. There is a good correlation between muscle mass assessed by MRI and BIA. Because MRI is performed in a great proportion of newly diagnosed CD patients it can also be used to assess the presence of sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, 10000 Zagreb, Croatia.
- Department of Pediatric Radiology, Children's Hospital Zagreb, 10000 Zagreb, Croatia.
- School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
- School of Medicine, University Josip Juraj Strossmayer Osijek, 31000 Osijek, Croatia.
ORCID-Profile: Sila Sara, Ivana Trivić Mažuranić, Zrinjka Mišak
Förderung
- Croatian Science Foundation
Zitieren
APA
Blagec, P., Sara, S., Tripalo Batoš, A., Trivić Mažuranić, I., Močić Pavić, A., Mišak, Z., & Hojsak, I. (2023). Magnetic Resonance Imaging Can Be Used to Assess Sarcopenia in Children with Newly Diagnosed Crohn’s Disease. Nutrients. https://doi.org/10.3390/nu15173838
Vancouver
Blagec P, Sara S, Tripalo Batoš A, Trivić Mažuranić I, Močić Pavić A, Mišak Z, et al. Magnetic Resonance Imaging Can Be Used to Assess Sarcopenia in Children with Newly Diagnosed Crohn’s Disease. Nutrients. 2023. doi:10.3390/nu15173838
BibTeX
@article{Blagec2023,
author = {Blagec, Paola and Sara, Sila and Tripalo Batoš, Ana and Trivić Mažuranić, Ivana and Močić Pavić, Ana and Mišak, Zrinjka and Hojsak, Iva},
title = {Magnetic Resonance Imaging Can Be Used to Assess Sarcopenia in Children with Newly Diagnosed Crohn’s Disease},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15173838}
}
EUVIMED